Literature DB >> 32401686

Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic.

Eva Segelov1, Craig Underhill2, Hans Prenen3, Christos Karapetis4, Christopher Jackson5, Louise Nott6, Tim Clay7, Nick Pavlakis8, Sabe Sabesan9, Ellen Heywood10, Christopher Steer2, Carrie Lethborg11, Hui K Gan12,13,14, Desmond Yip15, Narayan Karanth16, Deme Karikios17, C Raina MacIntyre18.   

Abstract

Cancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.

Entities:  

Mesh:

Year:  2020        PMID: 32401686     DOI: 10.1200/OP.20.00229

Source DB:  PubMed          Journal:  JCO Oncol Pract        ISSN: 2688-1527


  24 in total

Review 1.  Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic.

Authors:  Manit K Gundavda; Kaival K Gundavda
Journal:  SN Compr Clin Med       Date:  2020-11-21

2.  Outcome of oncological patients admitted with COVID-19: experience of a hospital center in northern Italy.

Authors:  Sara Cherri; Daniel H L Lemmers; Silvia Noventa; Mohammed Abu Hilal; Alberto Zaniboni
Journal:  Ther Adv Med Oncol       Date:  2020-09-30       Impact factor: 8.168

3.  Resilience and ongoing quality care for cancer clinical trials during COVID-19: Experience from a tertiary hospital in Australia.

Authors:  Amy Ives; Tricia Pusztai; Jacqui Keller; Elizabeth Ahern; Bryan Chan; Harry Gasper; David Wyld; Glen Kennedy; Graeme Dickie; Zarnie Lwin; Natasha A Roberts
Journal:  Asia Pac J Clin Oncol       Date:  2021-04-05       Impact factor: 1.926

4.  Protecting High-Risk Oncology Patients During the COVID-19 Pandemic by Creating an Isolated Outpatient Clinic.

Authors:  Seyed Mohammad Abedi; Manidhar Lekkala; Bahar Moftakhar; Tammy Clarke; Arpan Patel
Journal:  JCO Oncol Pract       Date:  2021-12-09

5.  Considerations for cancer immunotherapy during the COVID-19 pandemic.

Authors:  Yada Kanjanapan; Desmond Yip
Journal:  Med J Aust       Date:  2020-10-08       Impact factor: 7.738

6.  Technology-based Health Solutions for Cancer Caregivers to Better Shoulder the Impact of COVID-19: A Systematic Review Protocol.

Authors:  Zhaohui Su; Dean McDonnell; Bin Liang; Jennifer Kue; Xiaoshan Li; Sabina Šegalo; Shailesh Advani; Bertha E Flores; Jing Wang
Journal:  Res Sq       Date:  2020-09-01

Review 7.  Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemic.

Authors:  Kevin C J Yuen; Michael J Mortensen; Amir Azadi; Ekokobe Fonkem; James W Findling
Journal:  Endocrinol Diabetes Metab       Date:  2021-03-08

Review 8.  The Care of the Leukemic Patients in Times of SARS-CoV-2.

Authors:  Nabin Raj Karki; Thuy Le; Jorge Cortes
Journal:  Curr Oncol Rep       Date:  2021-08-03       Impact factor: 5.075

9.  Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study.

Authors:  Monica Tang; Benjamin Daniels; Maria Aslam; Andrea Schaffer; Sallie-Anne Pearson
Journal:  Lancet Reg Health West Pac       Date:  2021-08-03

10.  Towards new models of cancer care in Australia: lessons from Victoria's response to the COVID-19 pandemic.

Authors:  Craig Underhill; Phillip Parente; Grant McArthur; Andrew Haydon; Sue-Anne McLachlan; Zee Wan Wong; Eva Segelov
Journal:  Intern Med J       Date:  2020-09-20       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.